Vaccination and natural infection both train the immune system, but only one route carries the added risk of long COVID and ...

COVID-19 vaccine resistance has shifted from acute ideological opposition toward broader apathy, a trend now spilling into ...

Eligibility required diary-confirmed perimenstrual attacks in ≥2 of 3 cycles and excluded chronic migraine and certain aura syndromes, strengthening interpretability for episodic menstrual patterns.

Data show that commercially and Medicaid-insured children with chronic or immunocompromising conditions incur 2- to 3-fold higher costs. A retrospective cohort study using the Merative MarketScan ...

Large-scale linkage analyses suggest prenatal SARS‑CoV‑2 exposure is not associated with most neurodevelopmental or neurological diagnoses in early childhood. Restricting to pre–March 2022 births ...

National claims data (>104 million adults) showed higher unadjusted GLP-1 use in SMI, but adjustment for indications and ...

According to a study in The Lancet Microbe, genomic surveillance and broader vaccine targeting are significant factors in ...

Johnson & Johnson now requires comprehensive pharmacy/medical claims elements to be submitted to its 340B ESP platform, with suspension of all 340B pricing within five business days after repeated ...

There is something special about PAINWeek beyond the obvious Vegas setting and the usual conference buzz of caffeinated colleagues sprinting from session to session, having hallwa ...

Aggregate OOP burden for generics exceeds brands due to utilization intensity, especially among Medicare beneficiaries with higher generic fill counts and near-parity annual OOP spending versus brands ...

Nirmatrelvir-ritonavir (Paxlovid) provided no measurable benefit for patients with long COVID, according to results from RECOVER-VITAL ( NCT05595369 ), a phase 2 randomized, double-blind, ...

James Barnes, CPhT, explains why respecting a patient's time isn't about speed and how he landed in the pharmacy by chance.